Position
Renaissance Technologies in Apyx Medical Corp
Back to the book · All holders of APYX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $241.9K$3.69 → $4.49
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 220.4K | $771.4K | — | — | — | 0.0% |
| Q1 2026 | 302.4K | $1.12M | $3.69 | $41.9K | $302.6K | 0.0% |
| Q2 2026 | 554.3K | $2.49M | $4.49 | $241.9K | $1.13M | 0.0% |